WO2018025590A1 - Procédé de production d'un composé hétérocyclique contenant de l'azote et composé hétérocyclique contenant de l'azote - Google Patents
Procédé de production d'un composé hétérocyclique contenant de l'azote et composé hétérocyclique contenant de l'azote Download PDFInfo
- Publication number
- WO2018025590A1 WO2018025590A1 PCT/JP2017/025102 JP2017025102W WO2018025590A1 WO 2018025590 A1 WO2018025590 A1 WO 2018025590A1 JP 2017025102 W JP2017025102 W JP 2017025102W WO 2018025590 A1 WO2018025590 A1 WO 2018025590A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- general formula
- structure represented
- nitrogen
- atom
- Prior art date
Links
- -1 nitrogen-containing heterocyclic compound Chemical class 0.000 title claims abstract description 40
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 29
- 150000001875 compounds Chemical class 0.000 claims abstract description 101
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims abstract description 38
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 claims abstract description 20
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229910052794 bromium Inorganic materials 0.000 claims abstract description 15
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims abstract description 11
- GGCZERPQGJTIQP-UHFFFAOYSA-N sodium;9,10-dioxoanthracene-2-sulfonic acid Chemical compound [Na+].C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 GGCZERPQGJTIQP-UHFFFAOYSA-N 0.000 claims abstract description 9
- 125000001424 substituent group Chemical group 0.000 claims description 24
- 229910052757 nitrogen Inorganic materials 0.000 claims description 18
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 16
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 15
- 229910052717 sulfur Inorganic materials 0.000 claims description 14
- 125000004434 sulfur atom Chemical group 0.000 claims description 14
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 13
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 239000002253 acid Substances 0.000 claims description 7
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 230000007613 environmental effect Effects 0.000 abstract description 6
- 230000002194 synthesizing effect Effects 0.000 abstract 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 230000015572 biosynthetic process Effects 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- 238000003786 synthesis reaction Methods 0.000 description 20
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 18
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 14
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 12
- 239000013078 crystal Substances 0.000 description 11
- 239000000203 mixture Substances 0.000 description 11
- 239000003054 catalyst Substances 0.000 description 9
- 239000010949 copper Substances 0.000 description 9
- 238000003756 stirring Methods 0.000 description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 9
- 238000010992 reflux Methods 0.000 description 7
- YPNVIBVEFVRZPJ-UHFFFAOYSA-L silver sulfate Chemical compound [Ag+].[Ag+].[O-]S([O-])(=O)=O YPNVIBVEFVRZPJ-UHFFFAOYSA-L 0.000 description 7
- 229910000367 silver sulfate Inorganic materials 0.000 description 7
- 229910000029 sodium carbonate Inorganic materials 0.000 description 7
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000001914 filtration Methods 0.000 description 6
- LVEYOSJUKRVCCF-UHFFFAOYSA-N 1,3-bis(diphenylphosphino)propane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCP(C=1C=CC=CC=1)C1=CC=CC=C1 LVEYOSJUKRVCCF-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Chemical compound P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 description 4
- 125000004466 alkoxycarbonylamino group Chemical group 0.000 description 4
- 230000000052 comparative effect Effects 0.000 description 4
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 4
- 125000000623 heterocyclic group Chemical group 0.000 description 4
- KZPYGQFFRCFCPP-UHFFFAOYSA-N 1,1'-bis(diphenylphosphino)ferrocene Chemical compound [Fe+2].C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=C[C-]1P(C=1C=CC=CC=1)C1=CC=CC=C1 KZPYGQFFRCFCPP-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- FPGGTKZVZWFYPV-UHFFFAOYSA-M tetrabutylammonium fluoride Chemical compound [F-].CCCC[N+](CCCC)(CCCC)CCCC FPGGTKZVZWFYPV-UHFFFAOYSA-M 0.000 description 3
- BWHDROKFUHTORW-UHFFFAOYSA-N tritert-butylphosphane Chemical compound CC(C)(C)P(C(C)(C)C)C(C)(C)C BWHDROKFUHTORW-UHFFFAOYSA-N 0.000 description 3
- KJCVRFUGPWSIIH-UHFFFAOYSA-N 1-naphthol Chemical compound C1=CC=C2C(O)=CC=CC2=C1 KJCVRFUGPWSIIH-UHFFFAOYSA-N 0.000 description 2
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Chemical compound CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 2
- 229910021589 Copper(I) bromide Inorganic materials 0.000 description 2
- 229910021591 Copper(I) chloride Inorganic materials 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- UEEJHVSXFDXPFK-UHFFFAOYSA-N N-dimethylaminoethanol Chemical compound CN(C)CCO UEEJHVSXFDXPFK-UHFFFAOYSA-N 0.000 description 2
- 101150003085 Pdcl gene Proteins 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 125000002252 acyl group Chemical group 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 125000004423 acyloxy group Chemical group 0.000 description 2
- 125000003342 alkenyl group Chemical group 0.000 description 2
- 125000003545 alkoxy group Chemical group 0.000 description 2
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 2
- 125000003282 alkyl amino group Chemical group 0.000 description 2
- 125000004414 alkyl thio group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 125000005162 aryl oxy carbonyl amino group Chemical group 0.000 description 2
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 2
- 125000005110 aryl thio group Chemical group 0.000 description 2
- 125000004104 aryloxy group Chemical group 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- LLEMOWNGBBNAJR-UHFFFAOYSA-N biphenyl-2-ol Chemical compound OC1=CC=CC=C1C1=CC=CC=C1 LLEMOWNGBBNAJR-UHFFFAOYSA-N 0.000 description 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- OXBLHERUFWYNTN-UHFFFAOYSA-M copper(I) chloride Chemical compound [Cu]Cl OXBLHERUFWYNTN-UHFFFAOYSA-M 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- 125000004093 cyano group Chemical group *C#N 0.000 description 2
- 125000000753 cycloalkyl group Chemical group 0.000 description 2
- 238000005401 electroluminescence Methods 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000003446 ligand Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 description 2
- 125000005499 phosphonyl group Chemical group 0.000 description 2
- 229910000073 phosphorus hydride Inorganic materials 0.000 description 2
- SIOXPEMLGUPBBT-UHFFFAOYSA-N picolinic acid Chemical compound OC(=O)C1=CC=CC=N1 SIOXPEMLGUPBBT-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- IUVKMZGDUIUOCP-BTNSXGMBSA-N quinbolone Chemical compound O([C@H]1CC[C@H]2[C@H]3[C@@H]([C@]4(C=CC(=O)C=C4CC3)C)CC[C@@]21C)C1=CCCC1 IUVKMZGDUIUOCP-BTNSXGMBSA-N 0.000 description 2
- 125000004469 siloxy group Chemical group [SiH3]O* 0.000 description 2
- CQLFBEKRDQMJLZ-UHFFFAOYSA-M silver acetate Chemical compound [Ag+].CC([O-])=O CQLFBEKRDQMJLZ-UHFFFAOYSA-M 0.000 description 2
- 229940071536 silver acetate Drugs 0.000 description 2
- NDVLTYZPCACLMA-UHFFFAOYSA-N silver oxide Chemical compound [O-2].[Ag+].[Ag+] NDVLTYZPCACLMA-UHFFFAOYSA-N 0.000 description 2
- SQGYOTSLMSWVJD-UHFFFAOYSA-N silver(1+) nitrate Chemical compound [Ag+].[O-]N(=O)=O SQGYOTSLMSWVJD-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 description 2
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 2
- WLPUWLXVBWGYMZ-UHFFFAOYSA-N tricyclohexylphosphine Chemical compound C1CCCCC1P(C1CCCCC1)C1CCCCC1 WLPUWLXVBWGYMZ-UHFFFAOYSA-N 0.000 description 2
- RIOQSEWOXXDEQQ-UHFFFAOYSA-N triphenylphosphine Chemical compound C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 RIOQSEWOXXDEQQ-UHFFFAOYSA-N 0.000 description 2
- 239000002699 waste material Substances 0.000 description 2
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 description 1
- YJTKZCDBKVTVBY-UHFFFAOYSA-N 1,3-Diphenylbenzene Chemical group C1=CC=CC=C1C1=CC=CC(C=2C=CC=CC=2)=C1 YJTKZCDBKVTVBY-UHFFFAOYSA-N 0.000 description 1
- VYGLGHJLGMSOKE-UHFFFAOYSA-N 1,3-bis(2,6-dimethylphenyl)-4,5-dihydroimidazol-1-ium Chemical compound CC1=CC=CC(C)=C1N1C=[N+](C=2C(=CC=CC=2C)C)CC1 VYGLGHJLGMSOKE-UHFFFAOYSA-N 0.000 description 1
- SCEZRJLZOZKPBC-UHFFFAOYSA-N 1,3-bis[2,6-di(propan-2-yl)phenyl]-4,5-dihydroimidazol-1-ium Chemical compound CC(C)C1=CC=CC(C(C)C)=C1N1C=[N+](C=2C(=CC=CC=2C(C)C)C(C)C)CC1 SCEZRJLZOZKPBC-UHFFFAOYSA-N 0.000 description 1
- ZXSQEZNORDWBGZ-UHFFFAOYSA-N 1,3-dihydropyrrolo[2,3-b]pyridin-2-one Chemical compound C1=CN=C2NC(=O)CC2=C1 ZXSQEZNORDWBGZ-UHFFFAOYSA-N 0.000 description 1
- YRAJNWYBUCUFBD-UHFFFAOYSA-N 2,2,6,6-tetramethylheptane-3,5-dione Chemical compound CC(C)(C)C(=O)CC(=O)C(C)(C)C YRAJNWYBUCUFBD-UHFFFAOYSA-N 0.000 description 1
- WOXFMYVTSLAQMO-UHFFFAOYSA-N 2-Pyridinemethanamine Chemical compound NCC1=CC=CC=N1 WOXFMYVTSLAQMO-UHFFFAOYSA-N 0.000 description 1
- 229940061334 2-phenylphenol Drugs 0.000 description 1
- NPAXPTHCUCUHPT-UHFFFAOYSA-N 3,4,7,8-tetramethyl-1,10-phenanthroline Chemical compound CC1=CN=C2C3=NC=C(C)C(C)=C3C=CC2=C1C NPAXPTHCUCUHPT-UHFFFAOYSA-N 0.000 description 1
- LMHIBYREWJHKNZ-UHFFFAOYSA-N 3-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=CN=C1C(O)=O LMHIBYREWJHKNZ-UHFFFAOYSA-N 0.000 description 1
- JIVLDFFWTQYGSR-UHFFFAOYSA-N 4,7-dimethyl-[1,10]phenanthroline Chemical compound C1=CC2=C(C)C=CN=C2C2=C1C(C)=CC=N2 JIVLDFFWTQYGSR-UHFFFAOYSA-N 0.000 description 1
- DHDHJYNTEFLIHY-UHFFFAOYSA-N 4,7-diphenyl-1,10-phenanthroline Chemical compound C1=CC=CC=C1C1=CC=NC2=C1C=CC1=C(C=3C=CC=CC=3)C=CN=C21 DHDHJYNTEFLIHY-UHFFFAOYSA-N 0.000 description 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 description 1
- BCJVBDBJSMFBRW-UHFFFAOYSA-N 4-diphenylphosphanylbutyl(diphenyl)phosphane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCCCP(C=1C=CC=CC=1)C1=CC=CC=C1 BCJVBDBJSMFBRW-UHFFFAOYSA-N 0.000 description 1
- LTUUGSGSUZRPRV-UHFFFAOYSA-N 6-methylpyridine-2-carboxylic acid Chemical compound CC1=CC=CC(C(O)=O)=N1 LTUUGSGSUZRPRV-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- CFXLXMCOYUXSFI-UHFFFAOYSA-N Brc(cc1)cc2c1[o]c1c2nccc1 Chemical compound Brc(cc1)cc2c1[o]c1c2nccc1 CFXLXMCOYUXSFI-UHFFFAOYSA-N 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- RAXXELZNTBOGNW-UHFFFAOYSA-O Imidazolium Chemical compound C1=C[NH+]=CN1 RAXXELZNTBOGNW-UHFFFAOYSA-O 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- 229930182821 L-proline Natural products 0.000 description 1
- KWYHDKDOAIKMQN-UHFFFAOYSA-N N,N,N',N'-tetramethylethylenediamine Chemical compound CN(C)CCN(C)C KWYHDKDOAIKMQN-UHFFFAOYSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- FBVBNCGJVKIEHH-UHFFFAOYSA-N c(cc1)cc2c1[o]c1c2nccc1 Chemical compound c(cc1)cc2c1[o]c1c2nccc1 FBVBNCGJVKIEHH-UHFFFAOYSA-N 0.000 description 1
- 125000001951 carbamoylamino group Chemical group C(N)(=O)N* 0.000 description 1
- RFUHYBGHIJSEHB-VGOFMYFVSA-N chembl1241127 Chemical compound C1=C(O)C(/C=N/O)=CC=C1C1=CC(O)=CC(O)=C1 RFUHYBGHIJSEHB-VGOFMYFVSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- SSJXIUAHEKJCMH-UHFFFAOYSA-N cyclohexane-1,2-diamine Chemical compound NC1CCCCC1N SSJXIUAHEKJCMH-UHFFFAOYSA-N 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical group C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- BRARRAHGNDUELT-UHFFFAOYSA-N hydroxypicolinic acid Natural products OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 1
- 125000005462 imide group Chemical group 0.000 description 1
- 150000003949 imides Chemical class 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- KVKFRMCSXWQSNT-UHFFFAOYSA-N n,n'-dimethylethane-1,2-diamine Chemical compound CNCCNC KVKFRMCSXWQSNT-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010292 orthophenyl phenol Nutrition 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 229910052763 palladium Inorganic materials 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 150000005041 phenanthrolines Chemical class 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 229940081066 picolinic acid Drugs 0.000 description 1
- IUGYQRQAERSCNH-UHFFFAOYSA-N pivalic acid Chemical compound CC(C)(C)C(O)=O IUGYQRQAERSCNH-UHFFFAOYSA-N 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 150000003222 pyridines Chemical class 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- LKZMBDSASOBTPN-UHFFFAOYSA-L silver carbonate Substances [Ag].[O-]C([O-])=O LKZMBDSASOBTPN-UHFFFAOYSA-L 0.000 description 1
- 229910001958 silver carbonate Inorganic materials 0.000 description 1
- 229910001961 silver nitrate Inorganic materials 0.000 description 1
- 229910001923 silver oxide Inorganic materials 0.000 description 1
- FJOLTQXXWSRAIX-UHFFFAOYSA-K silver phosphate Chemical compound [Ag+].[Ag+].[Ag+].[O-]P([O-])([O-])=O FJOLTQXXWSRAIX-UHFFFAOYSA-K 0.000 description 1
- 229940019931 silver phosphate Drugs 0.000 description 1
- 229910000161 silver phosphate Inorganic materials 0.000 description 1
- VNFWTIYUKDMAOP-UHFFFAOYSA-N sphos Chemical compound COC1=CC=CC(OC)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 VNFWTIYUKDMAOP-UHFFFAOYSA-N 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000565 sulfonamide group Chemical group 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- UQFSVBXCNGCBBW-UHFFFAOYSA-M tetraethylammonium iodide Chemical compound [I-].CC[N+](CC)(CC)CC UQFSVBXCNGCBBW-UHFFFAOYSA-M 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- TUQOTMZNTHZOKS-UHFFFAOYSA-N tributylphosphine Chemical compound CCCCP(CCCC)CCCC TUQOTMZNTHZOKS-UHFFFAOYSA-N 0.000 description 1
- UGOMMVLRQDMAQQ-UHFFFAOYSA-N xphos Chemical compound CC(C)C1=CC(C(C)C)=CC(C(C)C)=C1C1=CC=CC=C1P(C1CCCCC1)C1CCCCC1 UGOMMVLRQDMAQQ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- C07D491/048—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being five-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B61/00—Other general methods
Definitions
- the present invention relates to a method for producing a nitrogen-containing heterocyclic compound and a nitrogen-containing heterocyclic compound. More specifically, the present invention relates to a method for producing a nitrogen-containing heterocyclic compound that can provide a nitrogen-containing heterocyclic compound useful as a material for an organic electroluminescence device in a high yield.
- the present invention has been made in view of the above problems and circumstances, and the solution to the problem is to provide a method for producing a nitrogen-containing heterocyclic compound having high yield and high purity and excellent production suitability and environmental suitability. That is.
- the present inventor made a high yield by reacting a compound having a specific structure with bromine in the presence of silver salt, sulfuric acid and carboxylic acid.
- the inventors have found that a method for producing a nitrogen-containing heterocyclic compound having a specific structure that is highly pure and excellent in production suitability and environmental suitability can be obtained, and the present invention has been achieved. That is, the said subject of this invention is solved by the following means.
- a compound having the structure represented by the following general formula [1] is reacted with bromine in the presence of silver salt, sulfuric acid and carboxylic acid to synthesize a compound having the structure represented by the following general formula [2].
- a method for producing a nitrogen-containing heterocyclic compound In the formula, X represents an oxygen atom or a sulfur atom.
- a 1 to A 4 each represents a nitrogen atom or CR. However, at least one of A 1 to A 4 is a nitrogen atom.
- R 1 to R 3 each represents a hydrogen atom or a substituent.
- the compound having a structure represented by the general formula [1] is a compound having a structure represented by the following general formula [3], and a compound having a structure represented by the general formula [2]
- X represents an oxygen atom or a sulfur atom.
- R 1 to R 6 each represents a hydrogen atom or a substituent.
- the compound having a structure represented by the general formula [1] is a compound having a structure represented by the following general formula [5], and a compound having a structure represented by the general formula [2]
- claim which is a compound which has a structure represented by following General formula [6].
- X represents an oxygen atom or a sulfur atom.
- X 1 represents a bromine atom or an iodine atom.
- R 1 to R 5 each represents a hydrogen atom or a substituent.
- a nitrogen-containing heterocyclic compound which is a compound having a structure represented by the following general formula [6].
- X represents an oxygen atom or a sulfur atom.
- X 1 represents a bromine atom or an iodine atom.
- R 1 to R 5 each represents a hydrogen atom or a substituent.
- the method for producing a nitrogen-containing heterocyclic compound of the present invention comprises reacting a compound having the structure represented by the general formula [1] with bromine in the presence of a silver salt, sulfuric acid and carboxylic acid, A compound having a structure represented by [2] is synthesized. Moreover, the nitrogen-containing heterocyclic compound of the present invention is a compound having a structure represented by the general formula [6].
- the compound having the structure represented by the general formula [1] is a compound having the structure represented by the general formula [3], and the compound having the structure represented by the general formula [2]. Is preferably a compound having a structure represented by the general formula [4].
- the compound having the structure represented by the general formula [1] is a compound having the structure represented by the general formula [5], and the compound having the structure represented by the general formula [2]. Is preferably a compound having a structure represented by the general formula [6].
- the compound represented by the general formula [8] is obtained by reacting a compound having the structure represented by the general formula [2] with a compound having a structure represented by the general formula [7] and further reacting with an acid. It is preferable to produce a compound having the structure
- ⁇ is used to mean that the numerical values described before and after it are included as a lower limit value and an upper limit value.
- X represents an oxygen atom or a sulfur atom.
- a 1 to A 4 each represent a nitrogen atom or CR. However, at least one of A 1 to A 4 is a nitrogen atom.
- R and R 1 to R 3 each represent a hydrogen atom or a substituent.
- X represents an oxygen atom or a sulfur atom, and among the groups represented by X, an oxygen atom is particularly preferable.
- a 1 ⁇ A 4 represent a nitrogen atom or a CR. However, at least one of A 1 to A 4 is a nitrogen atom, preferably one is a nitrogen atom, and particularly preferably A 1 is a nitrogen atom.
- Examples of the substituent represented by R and R 1 to R 3 include an alkyl group, a cycloalkyl group, an alkenyl group, an aryl group, an acylamino group, a sulfonamide group, an alkylthio group, an arylthio group, a halogen atom, a heterocyclic ring ( For example, dibenzofuran ring, azadibenzofuran ring, etc.) group, sulfonyl group, sulfinyl group, phosphonyl group, acyl group, carbamoyl group, sulfamoyl group, cyano group, alkoxy group, aryloxy group, heterocyclic oxy group, siloxy group, acyloxy group, Carbamoyloxy, amino, alkylamino, imide, ureido, sulfamoylamino, alkoxycarbonylamino, alkoxycarbonylamin
- any of the above substituents may be further substituted with a substituent, for example, an alkyl group, a cycloalkyl group, an alkenyl group, an aryl group, an acylamino group, a sulfonamido group, an alkylthio group, an arylthio group, a halogen atom, Heterocyclic group, sulfonyl group, sulfinyl group, phosphonyl group, acyl group, carbamoyl group, sulfamoyl group, cyano group, alkoxy group, aryloxy group, heterocyclic oxy group, siloxy group, acyloxy group, carbamoyloxy group, amino group, Examples include alkylamino groups, imide groups, ureido groups, sulfamoylamino groups, alkoxycarbonylamino groups, alkoxycarbonylamino groups, aryloxycarbonylamino
- the amount of bromine used in the present invention is preferably within a range of 0.8 to 1.3 times, particularly preferably 0.9, in terms of molar ratio to the compound having the structure represented by the general formula [1]. It is in the range of -1.2 times.
- silver salt used in the present invention examples include silver acetate, silver sulfate, silver carbonate, silver nitrate, silver phosphate, silver oxide, and silver halide. Of these, silver sulfate is preferred.
- the amount of silver salt used in the present invention is preferably in the range of 0.3 to 3 mol, particularly preferably 0.5 to 1.5 mol, relative to 1 mol of the compound having the structure represented by the general formula [1]. Within range.
- the amount of sulfuric acid used in the present invention is preferably in the range of 1 to 5 mL, particularly preferably in the range of 1 to 3 mL, with respect to 1 g of the compound having the structure represented by the general formula [1].
- carboxylic acid used in the present invention examples include acetic acid, propionic acid, butyric acid, pivalic acid, benzoic acid and the like, and acetic acid is particularly preferable.
- Advantages of using carboxylic acid are that the reaction becomes mild and can suppress the formation of by-products, that stirring is good and that production is excellent, and that carboxylic acid is a weak acid, so it is not necessary to neutralize waste liquid and environmental suitability. For example, it is excellent.
- the amount of the carboxylic acid used in the present invention is preferably in the range of 5 to 50 mL, particularly preferably in the range of 10 to 30 mL, with respect to 1 g of the compound having the structure represented by the general formula [1].
- the reaction rate (measured by HPLC) is improved and the yield can be improved.
- the yield is preferably 75% or more, and particularly preferably 80% or more.
- the amount of water used in the present invention is preferably in the range of 1 to 5 mL, particularly preferably in the range of 1 to 3 mL with respect to 1 g of the compound having the structure represented by the general formula [1].
- the compound having a structure represented by the general formula [1] is a compound having a structure represented by the following general formula [3], and a compound having a structure represented by the general formula [2] Is preferably a compound having a structure represented by the following general formula [4].
- X represents an oxygen atom or a sulfur atom.
- R 1 to R 6 each represent a hydrogen atom or a substituent.
- Substituents represented by R 1 ⁇ R 6 has the general formula [1] and can use the same as the substituent represented by R 1 ⁇ R 6 of [2], further be substituted with a substituent The same applies to the points that may be used.
- the compound having a structure represented by the general formula [1] is a compound having a structure represented by the following general formula [5], and a compound having a structure represented by the general formula [2]
- a compound having a structure represented by the following general formula [6] is preferable.
- the nitrogen-containing heterocyclic compound of the present invention is a compound having a structure represented by the following general formula [6].
- R 1 to R 5 can be the same as the substituents represented by R 1 to R 6 in the general formulas [1] and [2], and are further substituted with substituents. The same applies to the points that may be used.
- X 1 represents a bromine atom or an iodine atom, and among the groups represented by X 1 , preferred is an iodine atom.
- the compound represented by the general formula [2] is reacted with a compound having the structure represented by the following general formula [7], and further reacted with an acid, thereby being represented by the following general formula [8]. It is preferable to produce a compound having the structure
- X represents an oxygen atom or a sulfur atom.
- a 1 to A 4 each represent a nitrogen atom or CR. However, at least one of A 1 to A 4 is a nitrogen atom.
- R and R 1 to R 3 represent a hydrogen atom or a substituent.
- R 7 represents an alkyl group or an aryl group. The substituents represented by R, R 1 to R 3 and R 7 may be the same as the substituents represented by R 1 to R 6 in the general formulas [1] and [2]. The point which may be substituted by group is also the same.
- Examples of the alkyl group represented by R 7 include a methyl group, an ethyl group, an n-propyl group, an iso-propyl group, an n-butyl group, a pentyl group, and an octyl group.
- Examples of the aryl group represented by R 7 include a phenyl group, a biphenyl group, and a terphenyl group.
- the acid used after reacting the compound having the structure represented by the general formula [2] and the compound having the structure represented by the general formula [7] is not particularly limited, but sulfuric acid, concentrated hydrochloric acid, phosphoric acid , Acetic acid, tosylic acid or methanesulfonic acid.
- the reaction temperature is usually preferably in the range of 0 to 40 ° C., particularly preferably in the range of 10 to 30 ° C.
- Pd catalyst When the compound having the structure represented by the general formula [2] and the compound having the structure represented by the general formula [7] are reacted, it is preferable to use a Pd catalyst or a Cu catalyst, and particularly preferably a Pd catalyst.
- the Pd catalyst that can be used include, but are not limited to, PdCl 2 , Pd (OAc) 2 , Pd (pph 3 ) 4 , PdCl 2 (dppf), Pd (dba) 2 , and Pd / C.
- a ligand may be used in combination with a Pd catalyst.
- a trialkylphosphine for example, tributylphosphine, tri-t-butylphosphine, tricyclohexylphosphine
- a phosphine having at least one aryl group for example, triphenylphosphine, SPhos, XPhos) , T-BuXPhos etc.
- phosphine having one aryl group is preferable, and t-BuXPhos is particularly preferable.
- Cu catalyst As it can be used as a Cu catalyst is not particularly limited CuCl, CuCl 2, CuBr, CuBr 2, CuI, CuI 2, CuO, Cu 2 O, CuSO 4, Cu 2 SO 4, CuOCOCH 3, Cu (OCOCH 3 ) 2 etc. are mentioned. Of these, CuI and Cu 2 O are particularly preferred.
- a ligand may be used in combination with a Cu catalyst.
- quaternary ammonium salts tetra-n-butylammonium fluoride (TBAF), tetraethylammonium iodide), 2,2′-bipyridine, tri (t-butyl) phosphine, 1,2-bis (diphenylphosphino) ethane (DPPE), 1,3-bis (diphenylphosphino) propane (DPPP), 1,4-bis (diphenylphosphino) butane (DPPB), 1,1′- Bis (diphenylphosphino) ferrocene (DPPF), tricyclohexylphosphine (PCy 3 ), aryl alcohols (eg 2-phenylphenol, 1-naphthol, 2,6-dimethylphenol, salicylaldoxime, N, N-diethylsalicyl) Amide, 8-hydroxyquinoline, etc.), alkyl Mines (eg 2- (dimethylamino) ethanol
- Synthesis example 1 (comparative example) ⁇ Synthesis of Exemplary Compound B-1 >> 34 g (0.2 mol) of exemplary compound A-1, 35 mL of sulfuric acid and 100 mL of water were mixed, and 65 g of silver sulfate and 48 g (0.3 mol) of bromine were added. Since the reaction did not proceed at room temperature, the mixture was heated to reflux for 5 hours, but stirring was insufficient. 80 mL of water was added and 84 g of sodium carbonate was added over 10 minutes. Extraction was performed with 5000 mL of a 1: 1 mixture of toluene / tetrahydrofuran (THF), and the solvent was removed. After refluxing with methanol, the crystals were filtered and dried to obtain 14.9 g of Exemplified Compound B-1 (yield 30%, purity 90.5%).
- THF toluene / tetrahydrofuran
- Synthesis Example 2 (present invention) ⁇ Synthesis of Exemplary Compound B-1 >> 34 g (0.2 mol) of Exemplified Compound A-1, 35 mL of sulfuric acid, 10 mL of water and 340 mL of acetic acid were mixed, and 65 g of silver sulfate and 35 g (0.22 mol) of bromine were added. The reaction proceeded at room temperature and stirring was sufficient. Stirring was carried out for 3 hours. 300 mL of water was added and 84 g of sodium carbonate was added over 10 minutes. Extraction with 800 mL of THF removed the solvent. After heating to reflux with methanol, the crystals were filtered and dried to obtain 40.1 g of Exemplified Compound B-1 (yield 81%, purity 98.4%).
- Synthesis example 3 (comparative example) ⁇ Synthesis of Exemplary Compound B-1 >> When the acetic acid of Synthesis Example 2 was replaced with the same amount of water, stirring was sufficient but the reaction did not proceed.
- Synthesis example 4 (comparative example) ⁇ Synthesis of Exemplary Compound B-1 >> 34 g (0.2 mol) of Exemplified Compound A-1, 375 mL of sulfuric acid and 10 mL of water were mixed, and 65 g of silver sulfate and 35 g (0.22 mol) of bromine were added. The reaction proceeded at room temperature and stirring was insufficient, but stirring was performed for 3 hours. 3000 mL of water was added and 895 g of sodium carbonate was added over 1 hour. Extraction with 5000 mL of THF removed the solvent. After heating to reflux with methanol, the crystals were filtered and dried to obtain 32 g of Exemplified Compound B-1 (yield 65%, purity 90.1%).
- Synthesis Example 5 (present invention) ⁇ Synthesis of Exemplary Compound B-4 >> 50 g (0.169 mol) of exemplary compound A-4, 100 mL of sulfuric acid, 50 mL of water and 1.2 L of acetic acid were mixed, and 52 g of silver sulfate was further added. 29.7 g (0.186 mol) of bromine was added dropwise over 10 minutes, and the mixture was further stirred for 3 hours. 500 mL of water was added and 240 g of sodium carbonate was added over 1 hour. The crystals were collected by filtration and dried. It was dissolved in 5 L of THF to remove insoluble matters. After concentration under reduced pressure, the mixture was heated to reflux with methanol, and the crystals were collected by filtration and dried to obtain 53.7 g of Exemplified Compound B-4 (yield 85%, purity 97.0%).
- Synthesis Example 6 (present invention) ⁇ Synthesis of Exemplary Compound B-4 >> 50 g (0.169 mol) of exemplary compound A-4, 100 mL of sulfuric acid, 50 mL of water, and 1.2 L of propionic acid were mixed, and 52 g of silver sulfate was further added. 29.7 g (0.186 mol) of bromine was added dropwise over 10 minutes, and the mixture was further stirred for 3 hours. 500 mL of water was added and 240 g of sodium carbonate was added over 1 hour. The crystals were collected by filtration and dried. It was dissolved in 5 L of THF to remove insoluble matters. After concentration under reduced pressure, the mixture was heated to reflux with methanol, and the crystals were collected by filtration and dried to obtain 51.2 g of Exemplified Compound B-4 (yield 81%, purity 96.7%).
- Synthesis Example 7 (present invention) ⁇ Synthesis of Exemplary Compound B-4 >> 50 g (0.169 mol) of exemplary compound A-4, 100 mL of sulfuric acid, 50 mL of water and 1.2 L of acetic acid were mixed, and 28 g of silver acetate was further added. 29.7 g (0.186 mol) of bromine was added dropwise over 10 minutes, and the mixture was further stirred for 3 hours. 500 mL of water was added and 240 g of sodium carbonate was added over 1 hour. The crystals were collected by filtration and dried. It was dissolved in 5 L of THF to remove insoluble matters. After concentration under reduced pressure, the mixture was heated to reflux with methanol, and the crystals were collected by filtration and dried to obtain 51.2 g of Exemplified Compound B-4 (yield 81%, purity 96.0%).
- Synthesis Example 8 (Comparative Example) ⁇ Synthesis of Exemplary Compound B-4 >> The acetic acid in Synthesis Example 5 was replaced with the same amount of water, but the reaction did not proceed.
- Synthesis Example 9 (present invention) ⁇ Synthesis of Exemplified Compound D-2 >> 8.9 g (0.0214 mol) of Exemplified Compound B-2, 5.0 g (0.0427 mol) of Exemplified Compound C-5, 4.1 g of t-C 4 H 9 ONa, and 160 mL of THF were added under a nitrogen stream. And stirred for 20 minutes. To this suspension, 1.3 g of Pd (dba) 2 and 0.7 g of t-BuXPhos were added and refluxed for 2 hours. After adding 600 mL of THF and removing insolubles, the mixture was concentrated under reduced pressure.
- the method for producing a nitrogen-containing heterocyclic compound of the present invention can be suitably used for producing, for example, a nitrogen-containing heterocyclic compound used as a material for an organic electroluminescence device.
- the nitrogen-containing heterocyclic compound manufactured by the manufacturing method of the nitrogen-containing heterocyclic compound of this invention and the nitrogen-containing heterocyclic compound of this invention can be used suitably as an organic electroluminescent element material, for example.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
La présente invention traite le problème de fournir un procédé de production, avec un rendement élevé, d'un composé hétérocyclique contenant de l'azote ayant une pureté élevée, une aptitude à la production supérieure, et une adéquation environnementale supérieure. Le procédé de production d'un composé hétérocyclique contenant de l'azote selon la présente invention comprend la synthèse d'un composé ayant une structure représentée par la formule générale [2], en faisant réagir un composé ayant une structure représentée par la formule générale [1] avec du brome en présence d'un sel d'argent, d'acide sulfurique et d'un acide carboxylique.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018531802A JP7071919B2 (ja) | 2016-08-02 | 2017-07-10 | 含窒素複素環化合物の製造方法及び含窒素複素環化合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016-151693 | 2016-08-02 | ||
JP2016151693 | 2016-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2018025590A1 true WO2018025590A1 (fr) | 2018-02-08 |
Family
ID=61072670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2017/025102 WO2018025590A1 (fr) | 2016-08-02 | 2017-07-10 | Procédé de production d'un composé hétérocyclique contenant de l'azote et composé hétérocyclique contenant de l'azote |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP7071919B2 (fr) |
WO (1) | WO2018025590A1 (fr) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006132295A1 (fr) * | 2005-06-09 | 2006-12-14 | Dainippon Sumitomo Pharma Co., Ltd. | Regulateur de recepteur d’aldosterone |
WO2009008100A1 (fr) * | 2007-07-10 | 2009-01-15 | Idemitsu Kosan Co., Ltd. | Matériau pour élément à électroluminescence organique, et élément à électroluminescence organique préparé à l'aide du matériau |
JP2011084531A (ja) * | 2009-10-19 | 2011-04-28 | Konica Minolta Holdings Inc | 有機エレクトロルミネッセンス素子用材料、有機エレクトロルミネッセンス素子、照明装置及び表示装置 |
WO2013038650A1 (fr) * | 2011-09-13 | 2013-03-21 | 出光興産株式会社 | Dérivé aromatique hétérocyclique condensé, matériau pour élément électroluminescent organique, et élément électroluminescent organique l'utilisant |
JP2014533237A (ja) * | 2011-08-02 | 2014-12-11 | 上海唐▲潤▼医▲葯▼科技有限公司 | Hcvプロテアーゼ阻害剤 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3475868B2 (ja) * | 1999-09-17 | 2003-12-10 | 松下電器産業株式会社 | 磁気抵抗効果型薄膜磁気ヘッド |
-
2017
- 2017-07-10 JP JP2018531802A patent/JP7071919B2/ja active Active
- 2017-07-10 WO PCT/JP2017/025102 patent/WO2018025590A1/fr active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006132295A1 (fr) * | 2005-06-09 | 2006-12-14 | Dainippon Sumitomo Pharma Co., Ltd. | Regulateur de recepteur d’aldosterone |
WO2009008100A1 (fr) * | 2007-07-10 | 2009-01-15 | Idemitsu Kosan Co., Ltd. | Matériau pour élément à électroluminescence organique, et élément à électroluminescence organique préparé à l'aide du matériau |
JP2011084531A (ja) * | 2009-10-19 | 2011-04-28 | Konica Minolta Holdings Inc | 有機エレクトロルミネッセンス素子用材料、有機エレクトロルミネッセンス素子、照明装置及び表示装置 |
JP2014533237A (ja) * | 2011-08-02 | 2014-12-11 | 上海唐▲潤▼医▲葯▼科技有限公司 | Hcvプロテアーゼ阻害剤 |
WO2013038650A1 (fr) * | 2011-09-13 | 2013-03-21 | 出光興産株式会社 | Dérivé aromatique hétérocyclique condensé, matériau pour élément électroluminescent organique, et élément électroluminescent organique l'utilisant |
Also Published As
Publication number | Publication date |
---|---|
JPWO2018025590A1 (ja) | 2019-05-30 |
JP7071919B2 (ja) | 2022-05-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2009096202A1 (fr) | Composé aromatique polycyclique halogéné et son procédé de production | |
AU2015371250B2 (en) | Process of making cenicriviroc and related analogs | |
JP2008063278A (ja) | 1−ピリジン−4−イル−インドール類の製造方法 | |
TWI644888B (zh) | 用於製備經取代之鄰胺苯甲酸衍生物之方法 | |
JP2001515879A (ja) | アリールオリゴアミン類の調製法 | |
CN105198841B (zh) | 一种药物中间体多取代呋喃类化合物的合成方法 | |
JP2008056615A (ja) | ビニルエチニルアリールカルボン酸類、その製造方法及びそれを用いた熱架橋性化合物の製造方法 | |
CN102863399B (zh) | 一种靛红酸酐衍生物的合成方法 | |
JP7071919B2 (ja) | 含窒素複素環化合物の製造方法及び含窒素複素環化合物 | |
CN103212339B (zh) | 一种季铵盐氟碳表面活性剂及其制备方法和应用 | |
CN106831603A (zh) | 一种含氟嘧啶化合物的制备方法 | |
CN110642831B (zh) | 一种在丙酮诱导下对芳烃或者杂芳烃进行氟烷基化的方法 | |
CN110357880B (zh) | 基于折叠体的具有圆偏振发光性质的手性荧光化合物及其制备方法与应用 | |
WO2019240033A1 (fr) | Procédé de production de diester d'acide dicyclohexanedicarboxylique et procédé de production d'acide dicyclohexanedicarboxylique | |
JP4070370B2 (ja) | 多環式芳香族化合物の製造方法 | |
JP6344003B2 (ja) | イリジウム錯体化合物の製造方法、及びその製造方法で得られたイリジウム錯体化合物 | |
JP5505450B2 (ja) | 含窒素多環複素環化合物の製造方法 | |
CN114621109B (zh) | 一种阿帕他胺的合成方法及其中间体 | |
JP6566085B2 (ja) | イリジウム錯体化合物の製造方法、及びその製造方法で得られたイリジウム錯体化合物 | |
WO2021024675A1 (fr) | Composé et son procédé de fabrication | |
KR20190039087A (ko) | 정제된 세니크리비록 및 세니크리비록을 제조하기 위한 정제된 중간체 | |
CN106957253A (zh) | 一种医药中间体2‑芳基吲哚化合物的合成方法 | |
CN108473431B (zh) | 2-氨基烟酸苄酯衍生物的制造方法 | |
JP2013155128A (ja) | イリジウム錯体及びその製造方法 | |
JP4475901B2 (ja) | 3−アセチルチオフェン類の製造方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ENP | Entry into the national phase |
Ref document number: 2018531802 Country of ref document: JP Kind code of ref document: A |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 17836697 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 17836697 Country of ref document: EP Kind code of ref document: A1 |